Brief: Yichang Hec Changjiang Pharmaceutical Sees Net Loss Attributable Ranging From Rmb494 Mln To Rmb556 Mln For HY
24/08/2021 16:07
Aug 24 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* SEES NET LOSS ATTRIBUTABLE RANGING FROM ABOUT RMB494
MILLION TO
ABOUT RMB556 MILLION FOR SIX MONTHS
Further company coverage: 1558.HK
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million